P. Shah, A. Roth, R. Goya, A. Oloumi, G. Ha et al., The clonal and mutational evolution spectrum of primary triple-negative breast cancers, Nature, vol.464, pp.385-399, 2012.
DOI : 10.1038/nature10933

S. Banerji, K. Cibulskis, K. Rangel-escareno, K. Brown, S. Carter et al., Sequence analysis of mutations and translocations across breast cancer subtypes, Nature, vol.274, issue.7403, pp.405-409, 2012.
DOI : 10.1038/nature11154

M. Ellis, L. Ding, D. Shen, J. Luo, V. Suman et al., Whole-genome analysis informs breast cancer response to aromatase inhibition, Nature, vol.19, pp.353-360, 2012.
DOI : 10.1038/nature11143

D. Birnbaum, F. Sircoulomb, and J. Imbert, A reason why the ERBB2 gene is amplified and not mutated in breast cancer, Cancer Cell International, vol.9, issue.1, p.5, 2009.
DOI : 10.1186/1475-2867-9-5

N. Hynes and G. Macdonald, ErbB receptors and signaling pathways in cancer, Current Opinion in Cell Biology, vol.21, issue.2, pp.177-184, 2009.
DOI : 10.1016/j.ceb.2008.12.010

G. Wu, X. Feng, L. Stein, and L. , A human functional protein interaction network and its application to cancer data analysis, Genome Biology, vol.11, issue.5, p.53, 2010.
DOI : 10.1186/gb-2010-11-5-r53

K. Oxford and D. Scadden, Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation, Nature Reviews Genetics, vol.13, issue.2, pp.115-127, 2008.
DOI : 10.1038/nrg2269

T. Burdon, A. Smith, and P. Savatier, Signalling, cell cycle and pluripotency in embryonic stem cells, Trends in Cell Biology, vol.12, issue.9, pp.432-438, 2002.
DOI : 10.1016/S0962-8924(02)02352-8

R. Cairns, I. Harris, and T. Mak, Regulation of cancer cell metabolism, Nature Reviews Cancer, vol.118, issue.2, pp.85-95, 2011.
DOI : 10.1038/nrc2981

A. Eijkelenboom and B. Burgering, FOXOs: signalling integrators for homeostasis maintenance, Nature Reviews Molecular Cell Biology, vol.14, issue.2, pp.83-97, 2013.
DOI : 10.1038/nrm3507

T. Grunt and G. Mariani, Novel Approaches for Molecular Targeted Therapy of Breast Cancer: Interfering with PI3K/AKT/mTOR Signaling, Current Cancer Drug Targets, vol.13, issue.2, pp.188-204, 2013.
DOI : 10.2174/1568009611313020008

F. Eisinger, H. Sobol, and D. Birnbaum, Hypothesis: more mutations to cure cancer?, Oncology Reports, vol.6, pp.1189-1190, 1999.
DOI : 10.3892/or.6.6.1189